XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.2

Business Segments (Tables)

3 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Operating and Reportable Segments

The tables below summarize information about our reportable segments.

			Three Months Ended June 30, 2022
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	242,518					$	34,541											$	277,059
Cost of sales			102,921						14,019												116,940
Gross profit			139,597						20,522												160,119
Advertising and marketing			35,412						4,539												39,951
Contribution margin			$	104,185					$	15,983											120,168
Other operating expenses																					33,154
Operating income																					$	87,014
* Intersegment revenues of $0.5 million were eliminated from the North American OTC Healthcare segment.

			Three Months Ended June 30, 2021
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	242,393					$	26,788											$	269,181
Cost of sales			99,404						10,765												110,169
Gross profit			142,989						16,023												159,012
Advertising and marketing			35,230						4,209												39,439
Contribution margin			$	107,759					$	11,814											119,573
Other operating expenses																					28,231
Operating income																					$	91,342
* Intersegment revenues of $1.0 million were eliminated from the North American OTC Healthcare segment.

Revenues from Similar Product Groups

The tables below summarize information about our segment revenues from similar product groups.

			Three Months Ended June 30, 2022
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	27,797					$	453											$	28,250
Cough & Cold			21,592						6,271												27,863
Women's Health			61,184						4,867												66,051
Gastrointestinal			40,067						14,027												54,094
Eye & Ear Care			38,611						4,736												43,347
Dermatologicals			29,455						1,006												30,461
Oral Care			20,975						3,170												24,145
Other OTC			2,837						11												2,848
Total segment revenues			$	242,518					$	34,541											$	277,059

			Three Months Ended June 30, 2021
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	32,821					$	406											$	33,227
Cough & Cold			14,045						4,847												18,892
Women's Health			63,248						3,944												67,192
Gastrointestinal			42,366						10,204												52,570
Eye & Ear Care			35,987						3,458												39,445
Dermatologicals			31,150						939												32,089
Oral Care			20,967						2,989												23,956
Other OTC			1,809						1												1,810
Total segment revenues			$	242,393					$	26,788											$	269,181

Consolidated Goodwill and Intangible Assets Allocated to Reportable Segments

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration